The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Breast cancer associated SNPs

You can choose there to inter keywords to search

Chr Position SNPID Disease/Trait name pvalue PMID
19 17430915 rs10259 Breast cancer (Estrogen receptor negative breast cancer) 7.08E-06 22976474
19 28289228 rs10401215 Gene expression of LOC642290 (probeID ILMN_1677124) in breast tumors 2.11E-22 22522925
19 17384003 rs10402468 Breast cancer risk (in BRCA1 mutation carriers) 1.62E-09 20852631
19 46098885 rs10405576 Gene expression of GPR4 (probeID ILMN_2074477) in breast tumors 4.56E-06 22522925
19 17389648 rs10406920 Breast cancer risk (in BRCA1 mutation carriers) 1.75E-09 20852631
19 40869182 rs10407447 Gene expression of BLVRB (probeID ILMN_1797793) in breast tumors 1.57E-10 22522925
19 52372976 rs10411161 Breast cancer 7.00E-06 21424380
19 17361064 rs10415471 Breast cancer risk (in BRCA1 mutation carriers) 3.08E-09 20852631
19 17385176 rs10416654 Breast cancer risk (in BRCA1 mutation carriers) 1.65E-09 20852631
19 17386006 rs10418154 Breast cancer risk (in BRCA1 mutation carriers) 1.69E-09 20852631
19 17386107 rs10418362 Breast cancer risk (in BRCA1 mutation carriers) 1.69E-09 20852631
19 17391328 rs10419397 Breast cancer risk (in BRCA1 mutation carriers) 9.89E-12 20852631
19 17352985 rs10419742 Breast cancer risk (in BRCA1 mutation carriers) 4.42E-08 20852631
19 17382505 rs10420922 Breast cancer risk (in BRCA1 mutation carriers) 2.37E-09 20852631
19 17352961 rs10421287 Breast cancer risk (in BRCA1 mutation carriers) 1.39E-09 20852631
19 17422036 rs10423120 Breast cancer risk (in BRCA1 mutation carriers) 9.21E-08 20852631
19 17379558 rs10424178 Breast cancer risk (in BRCA1 mutation carriers) 1.17E-09 20852631
19 17409671 rs10424198 Breast cancer risk (in BRCA1 mutation carriers) 6.57E-08 20852631
19 54952513 rs10425451 Gene expression of HS.131041 (probeID ILMN_1911059) in breast tumors 8.49E-27 22522925
19 17397244 rs10425939 Breast cancer risk (in BRCA1 mutation carriers) 1.55E-09 20852631
19 17389156 rs10426697 Breast cancer risk (in BRCA1 mutation carriers) 4.19E-08 20852631
19 18499815 rs1054564 Gene expression of LRRC25 (probeID ILMN_2150196) in breast tumors 3.02E-04 22522925
19 10402938 rs1056538 Breast cancer 1.00E-04 15604251
19 17403907 rs10648607 Breast cancer risk (in BRCA1 mutation carriers) 3.45E-07 20852631
19 17385381 rs11086064 Breast cancer risk (in BRCA1 mutation carriers) 2.05E-06 20852631
19 11508192 rs111956126 Breast cancer 2.40E-04 23555315
19 17443070 rs112319436 Breast cancer risk (in BRCA1 mutation carriers) 4.14E-07 20852631
19 17385380 rs11291512 Breast cancer 1.71E-09 20852631
19 17170885 rs1130222 Breast cancer 6.60E-05 23555315
19 17452993 rs113487706 Breast cancer risk (in BRCA1 mutation carriers) 2.76E-09 20852631
19 36340009 rs113825926 Breast cancer 4.40E-04 23555315
19 45206624 rs114907619 Breast cancer (Estrogen receptor positive breast cancer) 3.40E-05 23555315
19 17403361 rs11540855 Breast cancer risk (in BRCA1 mutation carriers) 1.65E-09 20852631
19 17437744 rs11666308 Breast cancer risk (in BRCA1 mutation carriers) 4.71E-07 20852631
19 17390478 rs11667618 Breast cancer risk (in BRCA1 mutation carriers) 3.22E-07 20852631
19 17390579 rs11667661 Breast cancer risk (in BRCA1 mutation carriers) 3.23E-07 20852631
19 17399625 rs11668840 Breast cancer risk (in BRCA1 mutation carriers) 3.55E-09 20852631
19 17399625 rs11668840 Breast cancer 3.61E-05 23468962
19 51299342 rs11668998 Gene expression of C19ORF48 (probeID ILMN_2383484) in breast tumors 2.07E-06 22522925
19 58960481 rs11669741 Breast cancer early age of onset 2.94E-04 18463975
19 53747024 rs116784215 Breast cancer (Estrogen receptor negative breast cancer) 5.60E-05 23555315
19 17383565 rs117304397 Breast cancer risk (in BRCA1 mutation carriers) 3.20E-08 20852631
19 17454873 rs117354423 Breast cancer risk (in BRCA1 mutation carriers) 6.05E-07 20852631
19 35260442 rs117610843 Breast cancer 1.80E-04 23555315
19 17383560 rs117934125 Breast cancer risk (in BRCA1 mutation carriers) 3.14E-08 20852631
19 52388546 rs11878583 Breast cancer 1.35E-04 21424380
19 56227165 rs11882068 Breast cancer (Estrogen receptor negative breast cancer) 3.25E-05 21062454
19 17376948 rs12104352 Breast cancer risk (in BRCA1 mutation carriers) 5.90E-07 20852631
19 17424947 rs12327712 Breast cancer risk (in BRCA1 mutation carriers) 9.66E-08 20852631
19 36230174 rs12459634 Gene expression of TMEM149 (probeID ILMN_1786426) in breast tumors 5.40E-49 22522925
19 36230174 rs12459634 Gene expression of U2AF1L4 (probeID ILMN_2386269) in breast tumors 9.29E-16 22522925
19 36230174 rs12459634 Gene expression of U2AF1L4 (probeID ILMN_1779177) in breast tumors 3.61E-10 22522925
19 3762119 rs12459781 Gene expression of MRPL54 (probeID ILMN_1658486) in breast tumors 3.28E-08 22522925
19 47126614 rs12459883 Gene expression of GNG8 (probeID ILMN_1693269) in breast tumors 1.58E-04 22522925
19 10666112 rs12459941 Gene expression of KRI1 (probeID ILMN_1751395) in breast tumors 5.16E-04 22522925
19 8532219 rs12610448 Gene expression of 41700 (probeID ILMN_1669592) in breast tumors 2.46E-30 22522925
19 50478932 rs12611411 Gene expression of VRK3 (probeID ILMN_1771697) in breast tumors 1.58E-48 22522925
19 17459902 rs12974368 Breast cancer risk (in BRCA1 mutation carriers) 1.77E-06 20852631
19 17401521 rs12974508 Breast cancer risk (in BRCA1 mutation carriers) 3.58E-09 20852631
19 17401680 rs12975707 Breast cancer risk (in BRCA1 mutation carriers) 3.81E-07 20852631
19 17377558 rs12980812 Breast cancer risk (in BRCA1 mutation carriers) 1.01E-08 20852631
19 17409380 rs12982058 Breast cancer risk (in BRCA1 mutation carriers) 2.47E-09 20852631
19 17371568 rs12982178 Breast cancer risk (in BRCA1 mutation carriers) 1.81E-09 20852631
19 39152908 rs12984247 Gene expression of CAPN12 (probeID ILMN_1787514) in breast tumors 7.38E-07 22522925
19 9301166 rs13345998 Gene expression of OR7D2 (probeID ILMN_1722426) in breast tumors 3.94E-18 22522925
19 438830 rs140148508 Breast cancer 2.70E-04 23555315
19 51957493 rs140402033 Breast cancer (Estrogen receptor negative breast cancer) 5.60E-05 23555315
19 50882619 rs1405655 Gene expression of NAPSB (probeID ILMN_2109416) in breast tumors 3.68E-24 22522925
19 50882619 rs1405655 Gene expression of NAPSA (probeID ILMN_1784040) in breast tumors 1.95E-15 22522925
19 50882619 rs1405655 Gene expression of NAPSB (probeID ILMN_1723043) in breast tumors 6.38E-09 22522925
19 2834336 rs142404413 Breast cancer 1.50E-04 23555315
19 58049931 rs144559367 Breast cancer (Estrogen receptor positive breast cancer) 1.40E-04 23555315
19 53057722 rs144870963 Breast cancer (Estrogen receptor negative breast cancer) 5.00E-05 23555315
19 17397481 rs1465581 Breast cancer risk (in BRCA1 mutation carriers) 1.07E-11 20852631
19 58946056 rs1465789 Breast cancer early age of onset 1.24E-04 18463975
19 13883099 rs1469071 Gene expression of C19ORF53 (probeID ILMN_1671374) in breast tumors 3.38E-05 22522925
19 13249098 rs150928114 Breast cancer 6.30E-05 23555315
19 48734262 rs150982505 Breast cancer (Estrogen receptor negative breast cancer) 5.70E-05 23555315
19 55373362 rs1654644 Breast cancer 3.24E-05 20872241
19 19720788 rs16996185 Gene expression of ATP13A1 (probeID ILMN_2134224) in breast tumors 1.09E-44 22522925
19 33370566 rs17206282 Gene expression of CCDC123 (probeID ILMN_1679971) in breast tumors 2.45E-16 22522925
19 33371193 rs17272267 Gene expression of SLC7A9 (probeID ILMN_1735445) in breast tumors 7.11E-13 22522925
19 11546269 rs17426435 Breast cancer 6.20E-04 23555315
19 3589461 rs182473859 Breast cancer 1.10E-04 23555315
19 46733560 rs187146043 Breast cancer (Estrogen receptor negative breast cancer) 1.90E-05 23555315
19 4953351 rs1982468 Recurrence-free survival in breast cancer patients receiving tamoxifen therapy 9.41E-08 22180457
19 4953351 rs1982468 Response to tamoxifen in breast cancer 1.62E-04 22180457
19 4816627 rs199784356 Breast cancer 1.00E-03 23555315
19 2425409 rs199844209 Breast cancer (Estrogen receptor negative breast cancer) 3.10E-05 23555315
19 55591614 rs200577842 Breast cancer (Estrogen receptor positive breast cancer) 4.40E-05 23555315
19 42840173 rs201180083 Breast cancer 2.20E-04 23555315
19 15572397 rs201708162 Breast cancer 4.60E-05 23555315
19 1038222 rs2020000 Gene expression of CNN2 (probeID ILMN_1770290) in breast tumors 2.20E-08 22522925
19 18368694 rs202121427 Breast cancer 2.60E-04 23555315
19 57723007 rs2074858 Breast cancer 3.10E-04 23555315
19 47068688 rs2082495 Gene expression of CALM3 (probeID ILMN_1666385) in breast tumors 1.85E-05 22522925
19 44642181 rs2085516 Gene expression of ZNF234 (probeID ILMN_2103397) in breast tumors 4.29E-22 22522925
19 44642181 rs2085516 Gene expression of ZNF234 (probeID ILMN_1740197) in breast tumors 6.56E-12 22522925
19 24403047 rs2160749 Breast cancer (male breast cancer) 1.37E-08 23001122
19 17337025 rs2288544 Breast cancer risk (in BRCA1 mutation carriers) 1.73E-06 20852631
19 6755007 rs2305806 Gene expression of TRIP10 (probeID ILMN_2161746) in breast tumors 5.47E-24 22522925
19 17394124 rs2363956 Breast cancer risk (in BRCA1 mutation carriers) 2.40E-10 20852631
19 17394124 rs2363956 Breast cancer risk (Excluding BRCA1 mutation carriers who developed ovarian cancer) 6.50E-10 20852631
19 17394124 rs2363956 Breast cancer 5.54E-09 20852631
19 17394124 rs2363956 "Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)" 2.00E-08 24325915
19 17394124 rs2363956 "Breast cancer risk (Estrogen receptor, progesterone receptor and HER2 negative)" 1.10E-07 20852631
19 17394124 rs2363956 Breast cancer risk (Excluding breast cancer cases diagnosed with breast cancer more than 5 years prior to study recruitment) 8.50E-07 20852631
19 17394124 rs2363956 Breast cancer (Estrogen receptor negative breast cancer) 1.69E-06 22976474
19 17394124 rs2363956 Breast cancer risk (BRCA1 Class 1 mutations only) 6.50E-06 20852631
19 17394124 rs2363956 Breast cancer risk (BRCA1 Class 2 mutations only) 1.30E-05 20852631
19 17394124 rs2363956 Breast cancer (Estrogen receptor negative breast cancer) 3.00E-04 20852631
19 17394124 rs2363956 Breast cancer risk (Estrogen receptor or progesterone receptor negative) 4.00E-04 20852631
19 17394124 rs2363956 Breast cancer 8.08E-04 23468962
19 17457552 rs2364542 Breast cancer risk (in BRCA1 mutation carriers) 2.87E-09 20852631
19 36720390 rs2438517 Gene expression of ZNF565 (probeID ILMN_2310019) in breast tumors 5.35E-10 22522925
19 5785935 rs2446193 Gene expression of DUS3L (probeID ILMN_1723235) in breast tumors 5.66E-28 22522925
19 55481669 rs269913 Gene expression of NLRP2 (probeID ILMN_1664878) in breast tumors 2.77E-21 22522925
19 51657600 rs273663 Gene expression of SIGLEC7 (probeID ILMN_2409384) in breast tumors 6.76E-08 22522925
19 17406167 rs28473003 Breast cancer risk (in BRCA1 mutation carriers) 1.66E-09 20852631
19 44068193 rs2854496 Gene expression of LOC653583 (probeID ILMN_1805853) in breast tumors 3.09E-28 22522925
19 36825458 rs2857 Gene expression of ZFP14 (probeID ILMN_1764694) in breast tumors 5.43E-18 22522925
19 33377053 rs2868197 Gene expression of CCDC123 (probeID ILMN_1679971) in breast tumors 1.58E-62 22522925
19 45359148 rs2927466 Gene expression of BCAM (probeID ILMN_2320280) in breast tumors 3.89E-04 22522925
19 887128 rs2930902 Gene expression of CFD (probeID ILMN_1777190) in breast tumors 2.04E-04 22522925
19 56424443 rs303997 Breast cancer 9.50E-04 23555315
19 17387176 rs34084277 Breast cancer risk (in BRCA1 mutation carriers) 3.75E-09 20852631
19 17407597 rs34546260 Breast cancer risk (in BRCA1 mutation carriers) 1.40E-09 20852631
19 17358189 rs34963425 Breast cancer risk (in BRCA1 mutation carriers) 3.05E-09 20852631
19 17376948 rs35256297 Breast cancer 5.90E-07 20852631
19 17386107 rs35552009 Breast cancer 1.69E-09 20852631
19 17382990 rs35604430 Breast cancer risk (in BRCA1 mutation carriers) 1.18E-09 20852631
19 17359299 rs35630819 Breast cancer risk (in BRCA1 mutation carriers) 1.24E-07 20852631
19 17359535 rs35686037 Breast cancer risk (in BRCA1 mutation carriers) 3.08E-09 20852631
19 17384267 rs3745185 Breast cancer risk (in BRCA1 mutation carriers) 5.78E-08 20852631
19 17384267 rs3745185 Breast cancer risk (BRCA1 Class 2 mutations only) 8.60E-08 20852631
19 17384267 rs3745185 Breast cancer 3.86E-07 20852631
19 17384267 rs3745185 Breast cancer risk (Excluding BRCA1 mutation carriers who developed ovarian cancer) 6.20E-07 20852631
19 17384267 rs3745185 Breast cancer risk (Excluding breast cancer cases diagnosed with breast cancer more than 5 years prior to study recruitment) 3.90E-05 20852631
19 17384267 rs3745185 Breast cancer 4.30E-05 22923054
19 17384267 rs3745185 Breast cancer risk (triple negative breast cancer) 8.10E-05 20852631
19 17384267 rs3745185 Breast cancer risk (BRCA1 Class 1 mutations only) 3.30E-04 20852631
19 58154305 rs3746209 Gene expression of ZNF211 (probeID ILMN_1811195) in breast tumors 7.83E-04 22522925
19 44286513 rs3760982 Breast cancer 2.00E-10 23535729
19 44286513 rs3760982 Breast cancer 2.10E-10 23535729
19 44286513 rs3760982 Breast cancer (invasive breast cancer) 1.60E-08 23535729
19 44286513 rs3760982 Breast cancer (Estrogen receptor positive breast cancer) 3.30E-07 23535729
19 52257673 rs3764542 Gene expression of FPR1 (probeID ILMN_2092118) in breast tumors 1.36E-04 22522925
19 17448660 rs3810204 Breast cancer (Estrogen receptor negative breast cancer) 9.15E-06 22976474
19 47138646 rs3810295 "Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)" 4.30E-05 24325915
19 16046650 rs3810427 Gene expression of CYP4F11 (probeID ILMN_1719883) in breast tumors 1.63E-61 22522925
19 16046650 rs3810427 Gene expression of CYP4F2 (probeID ILMN_1729439) in breast tumors 3.91E-06 22522925
19 31816779 rs3816963 Gene expression of MGC16169 (probeID ILMN_1769601) in breast tumors 7.87E-05 22522925
19 17426501 rs3826700 Gene expression of MRPL34 (probeID ILMN_1783681) in breast tumors 2.14E-09 22522925
19 17385380 rs3837926 Breast cancer risk (in BRCA1 mutation carriers) 1.71E-09 20852631
19 41431935 rs3844443 Breast cancer 3.90E-04 21908515
19 54708646 rs3844452 Gene expression of LILRB3 (probeID ILMN_1784884) in breast tumors 2.72E-11 22522925
19 36216056 rs3848662 Gene expression of TMEM149 (probeID ILMN_1786426) in breast tumors 2.79E-09 22522925
19 49368843 rs386597512 Breast cancer 7.80E-05 23555315
19 30192738 rs3926 Gene expression of C19ORF12 (probeID ILMN_1703695) in breast tumors 1.12E-31 22522925
19 17385380 rs398034105 Breast cancer 1.71E-09 20852631
19 17386107 rs398120865 Breast cancer 1.69E-09 20852631
19 44432840 rs411803 Gene expression of ZNF404 (probeID ILMN_1682227) in breast tumors 1.67E-04 22522925
19 7694021 rs4134813 Gene expression of PCP2 (probeID ILMN_1720093) in breast tumors 6.15E-10 22522925
19 1058176 rs4147918 Breast cancer (Estrogen receptor positive breast cancer) 1.70E-04 23555315
19 48659409 rs436303 Gene expression of PLA2G4C (probeID ILMN_1810191) in breast tumors 8.73E-06 22522925
19 17367585 rs4464206 Breast cancer risk (in BRCA1 mutation carriers) 1.38E-06 20852631
19 49376683 rs45533432 Breast cancer 1.50E-04 23555315
19 17390917 rs4609972 Breast cancer risk (in BRCA1 mutation carriers) 2.75E-09 20852631
19 46027752 rs4802260 Gene expression of VASP (probeID ILMN_1743646) in breast tumors 1.73E-52 22522925
19 43794153 rs4803595 Breast size (bra cup size in women) 7.41E-05 22747683
19 45459671 rs4803781 Gene expression of APOC2 (probeID ILMN_1802923) in breast tumors 1.67E-22 22522925
19 30183171 rs4805468 Gene expression of C19ORF12 (probeID ILMN_1703695) in breast tumors 2.23E-07 22522925
19 17390291 rs4808075 Breast cancer risk (in BRCA1 mutation carriers) 9.36E-12 20852631
19 17395401 rs4808076 Breast cancer risk (in BRCA1 mutation carriers) 1.63E-09 20852631
19 17354825 rs4808611 Breast cancer risk (in BRCA1 mutation carriers) 1.60E-10 20852631
19 17354825 rs4808611 Breast cancer 3.24E-09 20852631
19 17354825 rs4808611 Breast cancer risk (Excluding BRCA1 mutation carriers who developed ovarian cancer) 1.40E-08 20852631
19 17354825 rs4808611 Breast cancer risk (Excluding breast cancer cases diagnosed with breast cancer more than 5 years prior to study recruitment) 3.50E-08 20852631
19 17354825 rs4808611 Breast cancer (Estrogen receptor negative breast cancer) 8.59E-08 22976474
19 17354825 rs4808611 Breast cancer risk (triple negative breast cancer) 2.40E-05 20852631
19 17354825 rs4808611 Breast cancer risk (BRCA1 Class 1 mutations only) 4.80E-05 20852631
19 17354825 rs4808611 Breast cancer risk (BRCA1 Class 2 mutations only) 6.50E-05 20852631
19 17403033 rs4808616 Breast cancer risk (in BRCA1 mutation carriers) 1.30E-11 20852631
19 18571141 rs4808801 Breast cancer 4.60E-15 23535729
19 18571141 rs4808801 Breast cancer 5.00E-15 23535729
19 18571141 rs4808801 Breast cancer (invasive breast cancer) 4.50E-12 23535729
19 18571141 rs4808801 Breast cancer (Estrogen receptor positive breast cancer) 1.40E-09 23535729
19 18571141 rs4808801 Breast cancer (Estrogen receptor negative breast cancer) 3.00E-05 23535729
19 18571141 rs4808801 Breast cancer (Estrogen receptor negative breast cancer) 5.10E-05 23535733
19 18571141 rs4808801 Breast cancer (ductal cancer in situ breast cancer) 7.70E-05 23535729
19 49206145 rs516316 Gene expression of FUT2 (probeID ILMN_1794659) in breast tumors 1.13E-09 22522925
19 17388790 rs56028644 Breast cancer risk (in BRCA1 mutation carriers) 1.71E-09 20852631
19 17393925 rs56069439 Breast cancer risk (in BRCA1 mutation carriers) 1.06E-11 20852631
19 19407718 rs56388212 Gene expression of ATP13A1 (probeID ILMN_2134224) in breast tumors 1.48E-06 22522925
19 17372199 rs58925582 Breast cancer risk (in BRCA1 mutation carriers) 1.81E-09 20852631
19 17451369 rs60397819 Breast cancer risk (in BRCA1 mutation carriers) 1.99E-06 20852631
19 17401859 rs61494113 Breast cancer risk (in BRCA1 mutation carriers) 1.29E-11 20852631
19 17387254 rs61634114 Breast cancer risk (in BRCA1 mutation carriers) 1.71E-09 20852631
19 58067680 rs61734156 Breast cancer 2.80E-04 23555315
19 55748338 rs61743087 Breast cancer (Estrogen receptor positive breast cancer) 2.80E-04 23555315
19 17383602 rs62126227 Breast cancer risk (in BRCA1 mutation carriers) 3.13E-07 20852631
19 17409949 rs62126253 Breast cancer risk (in BRCA1 mutation carriers) 1.49E-06 20852631
19 46978569 rs6509279 Gene expression of FLJ10781 (probeID ILMN_1794490) in breast tumors 1.24E-55 22522925
19 52003331 rs6509544 Gene expression of SIGLEC12 (probeID ILMN_1676363) in breast tumors 3.78E-17 22522925
19 18502835 rs6512265 Breast cancer 2.00E-04 23555315
19 17394839 rs66753001 Breast cancer risk (in BRCA1 mutation carriers) 1.63E-09 20852631
19 17401404 rs67397200 Breast cancer risk (in BRCA1 mutation carriers) 1.25E-11 20852631
19 17385502 rs67412075 Breast cancer risk (in BRCA1 mutation carriers) 1.67E-09 20852631
19 17385681 rs67537524 Breast cancer risk (in BRCA1 mutation carriers) 2.05E-06 20852631
19 43798922 rs67822081 Breast size (bra cup size in women) 7.93E-05 22747683
19 17384651 rs67958024 Breast cancer risk (in BRCA1 mutation carriers) 1.65E-09 20852631
19 17363444 rs68179022 Breast cancer risk (in BRCA1 mutation carriers) 1.07E-09 20852631
19 38438505 rs705493 Gene expression of ZNF571 (probeID ILMN_2093864) in breast tumors 7.82E-06 22522925
19 17358188 rs71334692 Breast cancer risk (in BRCA1 mutation carriers) 3.60E-09 20852631
19 11275258 rs7187 Gene expression of KANK2 (probeID ILMN_1716089) in breast tumors 6.00E-05 22522925
19 51230490 rs722036 Gene expression of CLEC11A (probeID ILMN_1807359) in breast tumors 2.53E-05 22522925
19 17401315 rs7245873 Breast cancer risk (in BRCA1 mutation carriers) 3.84E-07 20852631
19 17363068 rs7246243 Breast cancer risk (in BRCA1 mutation carriers) 4.42E-08 20852631
19 17363059 rs7247167 Breast cancer risk (in BRCA1 mutation carriers) 4.42E-08 20852631
19 57762139 rs7248000 Breast cancer 3.50E-04 21908515
19 17366806 rs7248801 Breast cancer risk (in BRCA1 mutation carriers) 1.48E-06 20852631
19 49297794 rs7249134 Breast size (bra cup size in women) 1.64E-05 22747683
19 17423373 rs7249329 Breast cancer (Estrogen receptor negative breast cancer) 1.99E-05 22976474
19 2426037 rs7252121 Breast cancer 7.10E-04 23555315
19 52250761 rs7253284 Gene expression of FPR1 (probeID ILMN_2092118) in breast tumors 1.79E-26 22522925
19 43805731 rs7255346 Breast size (bra cup size in women) 8.86E-05 22747683
19 35667192 rs7255878 Gene expression of FXYD5 (probeID ILMN_2309848) in breast tumors 1.68E-08 22522925
19 49328875 rs7256714 Breast size (bra cup size in women) 7.22E-05 22747683
19 41947635 rs7260605 Breast cancer (Estrogen receptor positive breast cancer) 3.20E-04 23555315
19 39421388 rs730078 Gene expression of SARS2 (probeID ILMN_1655684) in breast tumors 8.59E-07 22522925
19 17358188 rs73012590 Breast cancer 3.60E-09 20852631
19 17364085 rs73012598 Breast cancer risk (in BRCA1 mutation carriers) 3.59E-09 20852631
19 17388014 rs73014418 Breast cancer risk (in BRCA1 mutation carriers) 1.72E-09 20852631
19 17468090 rs73016427 Breast cancer risk (in BRCA1 mutation carriers) 4.45E-07 20852631
19 17475225 rs73016432 Breast cancer risk (in BRCA1 mutation carriers) 2.17E-06 20852631
19 17383732 rs73509969 Breast cancer risk (in BRCA1 mutation carriers) 1.65E-09 20852631
19 17393449 rs73509996 Breast cancer risk (in BRCA1 mutation carriers) 1.77E-09 20852631
19 17398085 rs73511822 Breast cancer risk (in BRCA1 mutation carriers) 1.08E-11 20852631
19 17396942 rs748850 Breast cancer risk (in BRCA1 mutation carriers) 3.40E-09 20852631
19 17421470 rs75146030 Breast cancer risk (in BRCA1 mutation carriers) 9.04E-08 20852631
19 17316802 rs75251420 Breast cancer (Estrogen receptor negative breast cancer) 8.70E-06 23555315
19 17455453 rs75452709 Breast cancer risk (in BRCA1 mutation carriers) 5.60E-08 20852631
19 47877974 rs755326 Gene expression of DHX34 (probeID ILMN_1747506) in breast tumors 9.71E-04 22522925
19 44058098 rs762507 Gene expression of XRCC1 (probeID ILMN_1751743) in breast tumors 7.62E-09 22522925
19 50485758 rs768574 Gene expression of VRK3 (probeID ILMN_2348403) in breast tumors 1.12E-14 22522925
19 17420496 rs78265621 Breast cancer risk (in BRCA1 mutation carriers) 7.86E-07 20852631
19 49317098 rs78535883 Breast size (bra cup size in women) 9.76E-05 22747683
19 17357063 rs79411242 Breast cancer risk (in BRCA1 mutation carriers) 3.13E-09 20852631
19 54793188 rs798887 Gene expression of LILRA3 (probeID ILMN_1661631) in breast tumors 1.66E-04 22522925
19 57843920 rs8099984 Gene expression of ZNF543 (probeID ILMN_1716658) in breast tumors 6.35E-13 22522925
19 17392894 rs8100241 Breast cancer (BRCA1-carriers) 4.30E-13 23544013
19 17392894 rs8100241 Breast cancer risk (in BRCA1 mutation carriers) 1.60E-10 20852631
19 17392894 rs8100241 Breast cancer risk (Excluding BRCA1 mutation carriers who developed ovarian cancer) 4.50E-10 20852631
19 17392894 rs8100241 Breast cancer 3.91E-09 20852631
19 17392894 rs8100241 Breast cancer 4.00E-08 22976474
19 17392894 rs8100241 Breast cancer risk (Excluding breast cancer cases diagnosed with breast cancer more than 5 years prior to study recruitment) 4.50E-07 20852631
19 17392894 rs8100241 Breast cancer risk (BRCA1 Class 1 mutations only) 3.90E-06 20852631
19 17392894 rs8100241 Breast cancer risk (BRCA1 Class 2 mutations only) 1.60E-05 20852631
19 9485229 rs8103099 Gene expression of ZNF266 (probeID ILMN_2396786) in breast tumors 1.04E-14 22522925
19 41127465 rs8107014 Breast cancer early age of onset 4.76E-04 18463975
19 43792307 rs8107019 Breast size (bra cup size in women) 7.68E-05 22747683
19 17440542 rs8110408 Breast cancer risk (in BRCA1 mutation carriers) 1.32E-07 20852631
19 21776847 rs8111313 Gene expression of ZNF429 (probeID ILMN_1695413) in breast tumors 1.36E-05 22522925
19 17278384 rs8112726 Breast cancer risk (in BRCA1 mutation carriers) 5.19E-07 20852631
19 17389704 rs8170 Breast Cancer in BRCA1 mutation carriers 4.00E-13 23544013
19 17389704 rs8170 Breast cancer 9.00E-13 23535733
19 17389704 rs8170 Breast cancer (Estrogen receptor negative breast cancer) 9.30E-13 23535733
19 17389704 rs8170 Breast cancer risk (in BRCA1 mutation carriers) 1.50E-10 20852631
19 17389704 rs8170 Breast cancer (BRCA1-carriers) 4.80E-10 23544013
19 17389704 rs8170 Breast cancer 2.00E-09 20852631
19 17389704 rs8170 Breast cancer risk (Excluding BRCA1 mutation carriers who developed ovarian cancer) 4.50E-09 20852631
19 17389704 rs8170 Breast cancer (Estrogen receptor negative breast cancer) 4.93E-08 22976474
19 17389704 rs8170 Breast cancer risk (Excluding breast cancer cases diagnosed with breast cancer more than 5 years prior to study recruitment) 1.10E-07 20852631
19 17389704 rs8170 "Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)" 1.26E-07 24325915
19 17389704 rs8170 "Breast cancer risk (Estrogen receptor, progesterone receptor and HER2 negative)" 1.20E-06 20852631
19 17389704 rs8170 Breast cancer risk (BRCA1 Class 2 mutations only) 4.20E-06 20852631
19 17389704 rs8170 Breast cancer risk (BRCA1 Class 1 mutations only) 1.20E-04 20852631
19 17354586 rs891205 Breast cancer risk (in BRCA1 mutation carriers) 1.28E-06 20852631
19 57723013 rs917340 Breast cancer 2.80E-04 23555315
19 19459215 rs968525 Gene expression of KIAA0892 (probeID ILMN_1685631) in breast tumors 8.47E-46 22522925
Chr Position SNPID Disease/Trait name pvalue PMID

CopyRight © University of Miami, USA; Harbin Medical University, China